1065481-83-5 Usage
Uses
Used in Organic Synthesis:
2-(bromomethyl)-3-(2-chlorophenyl)-5,6-difluoroquinoxaline is used as a building block in organic synthesis for the creation of more complex molecules. Its diverse functional groups allow for a range of chemical reactions, facilitating the synthesis of novel compounds with potential applications in various fields.
Used in Pharmaceutical Development:
In the pharmaceutical industry, 2-(bromomethyl)-3-(2-chlorophenyl)-5,6-difluoroquinoxaline is utilized as a key intermediate in the development of new drugs. Its structural components can be incorporated into drug molecules to enhance their pharmacological properties, such as potency, selectivity, and bioavailability.
Used as a Reagent in Chemical Reactions:
2-(bromomethyl)-3-(2-chlorophenyl)-5,6-difluoroquinoxaline also serves as a reagent in various chemical reactions, enabling the transformation of other molecules into desired products. Its reactivity can be harnessed to facilitate specific chemical processes, such as cross-coupling reactions, which are crucial for the synthesis of pharmaceuticals and other specialty chemicals.
Used in Medicinal Chemistry and Drug Discovery:
Due to its structural features and potential biological activities, 2-(bromomethyl)-3-(2-chlorophenyl)-5,6-difluoroquinoxaline is a promising candidate in medicinal chemistry and drug discovery. It can be used to explore new chemical space and identify lead compounds with therapeutic potential, which can then be optimized for clinical development.
Check Digit Verification of cas no
The CAS Registry Mumber 1065481-83-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,6,5,4,8 and 1 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1065481-83:
(9*1)+(8*0)+(7*6)+(6*5)+(5*4)+(4*8)+(3*1)+(2*8)+(1*3)=155
155 % 10 = 5
So 1065481-83-5 is a valid CAS Registry Number.
1065481-83-5Relevant academic research and scientific papers
HETEROCYCLIC COMPOUNDS AND THEIR USES
-
, (2008/12/04)
Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity. The present invention also enables methods for treating cancers that are mediated, dependent on, or associated with p110 activity, including but not restricted to leukemias, such as acute myeloid leukaemia (AML), myelo-dysplastic syndrome (MDS), myelo-proliferative diseases (MPD), chronic myeloid leukemia (CML), T-cell acute lymphoblastic leukaemia (T-ALL), B-cell acute lymphoblastic leukaemia (B-ALL), non Hodgkins lymphoma (NHL), B-cell lymphoma and solid tumors, such as breast cancer.
